Mesa Laboratories, Inc.
NASDAQ:MLABHardware, Equipment & Parts
-$0.15 today
- Market cap
- $774.56M
- Beta
- 0.93
- P/E (TTM)
- 78.3
- EPS (TTM)
- $1.21
- Dividend yield
- 0.68%
Volume 0.07M
Average 0.16M
MLAB EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
Mesa Laboratories, Inc.NASDAQ: MLAB
EPS (Basic) · Q4 FY2026 · quarter ended Mar 2026
EPS (Basic) remains negative
Q4 FY2026 EPS (Basic) was -$0.75, compared with -$1.31 a year earlier. Trailing-twelve-month EPS (Basic) was $1.23. Over 3 fiscal years it compounded at +92.9% a year.
Context
- EPS (Basic) increased in 2 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 1 analysts of $11.49 (+841.4%) for the fiscal year ending Mar 2027, a step up from the +438.9% reported in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$0.75-213.6% QoQ
- Last fiscal yearMar 2026
- $1.22+438.9% YoY
- LTMMar 2026
- $1.23+441.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +42.7% | +201.7% | +159.0 pp |
| 1 year | +438.9% | +841.4% | +402.5 pp |
| 3-year CAGR | +92.9% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2026
- 1.22 USD
- Year-over-year change
- +438.9%
- 4-year CAGR
- +35.7%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 1.22 | +438.9% |
| FY2025 | 2025-03-31 | (0.36) | +99.2% |
| FY2024 | 2024-03-31 | (47.20) | -27864.7% |
| FY2023 | 2023-03-31 | 0.17 | -52.8% |
| FY2022 | 2022-03-31 | 0.36 | — |
EPS (Basic) vs competitors
How MLAB compares with its peers on the latest reported figures
- MLAB's LTM Mar 2026 EPS (Basic) of $1.23 is the 6th highest of the 11 companies compared; the peer median is $1.53.
- Its year-over-year change of +441.7% is the highest of 11, against a peer median of +17.5%.
- Over three fiscal years its annual growth of +92.9% compares with a peer median of -0.6%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | $18.99 | +9.5% | +0.1% | |
| LTM Jun 2026 | $8.33 | -29.2% | — | |
| LTM Jul 2026 | $5.09 | +18.9% | +3.1% | |
| LTM Jul 2026 | $2.1 | -11.0% | -22.7% | |
| LTM Jun 2026 | $1.95 | +14.0% | -0.6% | |
| LTM Mar 2026 | $1.23 | +441.7% | +92.9% | |
| LTM Sep 2026 | $1.1 | +120.0% | -13.5% | |
| LTM Mar 2026 | -$0.25 | +28.4% | — | |
| LTM Mar 2026 | -$0.43 | +81.2% | — | |
| LTM Sep 2026 | -$0.52 | +16.1% | — | |
| LTM Jun 2026 | -$0.54 | +60.6% | — | |
| Peer median (excluding MLAB) | $1.53 | +17.5% | -0.6% | |
Competitors are the stored peer set for MLAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 184.34M | 219.08M | 216.19M | 240.98M | 249.13M |
| Cost of Revenue | 75.25M | 85.39M | 82.94M | 90.11M | 90.86M |
| Gross Profit | 109.09M | 133.69M | 133.25M | 150.87M | 158.27M |
| Gross Margin | 59.2% | 61.0% | 61.6% | 62.6% | 63.5% |
| Research & Development | 15.77M | 20.49M | 19.3M | 19.52M | 20.31M |
| Selling, General & Admin | 88.62M | 109.88M | 111.49M | 115.02M | 119.45M |
| Operating Expenses | 104.39M | 130.37M | 405.33M | 134.53M | 139.76M |
| Depreciation & Amortization | 25.07M | 33.13M | 31.57M | 24.53M | 23.27M |
| EBITDA | 32.53M | 37.52M | (238.38M) | 42.35M | 35.29M |
| EBITDA Margin | 17.6% | 17.1% | -110.3% | 17.6% | 14.2% |
| Operating Income | 4.7M | 3.32M | (272.08M) | 16.34M | 18.51M |
| Operating Margin | 2.6% | 1.5% | -125.9% | 6.8% | 7.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 3.89M | 4.77M | 5.7M | 11.86M | 10.69M |
| Other Income / Expenses | (1.13M) | (3.71M) | (3.57M) | (10.38M) | (6.5M) |
| Income Before Tax | 3.57M | (389K) | (275.65M) | 5.96M | 12.01M |
| Pre-Tax Margin | 1.9% | -0.2% | -127.5% | 2.5% | 4.8% |
| Income Tax Expense | 1.7M | (1.32M) | (21.4M) | 7.94M | 5.3M |
| Net Income | 1.87M | 930K | (254.25M) | (1.97M) | 6.71M |
| Net Margin | 1.0% | 0.4% | -117.6% | -0.8% | 2.7% |
| EPS (Basic) | 0.36 | 0.17 | (47.20) | (0.36) | 1.22 |
| EPS (Diluted) | 0.35 | 0.17 | (47.20) | (0.36) | 1.21 |
| Weighted Avg Shares | 5.21M | 5.32M | 5.39M | 5.43M | 5.51M |
| Weighted Avg Shares (Diluted) | 5.34M | 5.36M | 5.39M | 5.43M | 5.57M |
Mesa Laboratories, Inc.
NASDAQ:MLAB
Intrinsic Alpha fair value
Locked
Current Price
$137.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.